1 study on XY-PEPTIDE-2 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
The study demonstrated that the small peptides effectively inhibited PLC-β enzyme activity in vitro in a dose-dependent manner. XY-peptide-1 showed potent inhibition against PLC-β1 with an IC50 of 95 nM, while XY-pept…
Free, no account — handy when you're working with XY-PEPTIDE-2.